← signals
2026-07-15·ASML·guidance change
highup

ASML raised its full-year 2026 net sales forecast from €36B-€40B to €43B-€45B and reported Q2 net sales of €9.3B (beat...

ASML raised its full-year 2026 net sales forecast from €36B-€40B to €43B-€45B and reported Q2 net sales of €9.3B (beat €8.8B est.) and net profit of €2.9B (beat €2.6B est.) CNBC.

window 30devidence 7confidence score 100price ASML $1775.64

confidence score

Strong evidence: 7 independent source classes support this read.

100
high confidence7 independent source classesothernewsmarketpasses publish gate
priced-in check

ASML has not made a large direction-matching 30-90 day move yet.

not priced in
as of 2026-07-147d n/a45d n/a90d +20%yahoo

signal brief

ASML raised its full-year 2026 net sales forecast from €36B-€40B to €43B-€45B and reported Q2 net sales of €9.3B (beat €8.8B est.) and net profit of €2.9B (beat €2.6B est.) CNBC. The company also announced that Intel will use its High NA EUV machines for Panther Lake laptop chips Reuters. CEO Christophe Fouquet cited "extremely strong" order intake and capacity expansion plans, targeting a 30% increase in low NA EUV and DUV immersion capacity Bloomberg.

What the sources said:

  • CNBC: "ASML on Wednesday raised its guidance for the second time this year and reported stronger-than-expected quarterly results as its customers continue to ramp up production of AI chips."
  • Reuters: "Intel has decided to use a high-end machine from ASML to manufacture some of its flagship Panther Lake laptop chips."
  • Bloomberg: "ASML raised its full-year sales forecast for the second time this year, as a surge in AI spending drives demand for its chip-making machines."
  • Digitimes: "ASML raises 2026 sales outlook as AI-fueled logic and memory demand accelerates."

The guidance raise and Intel design win signal strong demand for advanced lithography equipment, benefiting ASML and its customers like TSMC, Intel, and memory makers. The stock jumped over 7% following the news.

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.